I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms

Description

This study is a randomized, controlled trial (RCT) to evaluate the effect of Brain CareNotes (a mobile health application) on the burden experienced by unpaid caregivers of patients with dementia and on the behavioral and psychological symptoms of dementia (BPSD) displayed by care recipients. Over 39 months, the trial will enroll 160 caregivers of community-dwelling patients diagnosed with Alzheimer's disease or a related dementia (ADRD). Caregivers will be randomized to use the Brain CareNotes app or an attention control education-only app for 12 months, with usage reminders.

Conditions

Caregiver Burden, Alzheimer Disease

Talk to us

Study Overview

On this page

Study Details

Study overview

This study is a randomized, controlled trial (RCT) to evaluate the effect of Brain CareNotes (a mobile health application) on the burden experienced by unpaid caregivers of patients with dementia and on the behavioral and psychological symptoms of dementia (BPSD) displayed by care recipients. Over 39 months, the trial will enroll 160 caregivers of community-dwelling patients diagnosed with Alzheimer's disease or a related dementia (ADRD). Caregivers will be randomized to use the Brain CareNotes app or an attention control education-only app for 12 months, with usage reminders.

I-CARE 2 RCT: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms for Caregivers and Patients

I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms

Condition
Caregiver Burden
Intervention / Treatment

-

Contacts and Locations

Indianapolis

IU Health, Indianapolis, Indiana, United States, 46202

Indianapolis

Community Health Network, Indianapolis, Indiana, United States, 46203

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Self-identified primary unpaid caregiver of a person diagnosed with ADRD (at any stage) who are:
  • * Receiving primary care and
  • * Community-dwelling;
  • * English literate;
  • * Age ≥ 18 years
  • * Care recipient is a permanent resident of an extended care facility (nursing home);
  • * Involvement in another clinical trial that would prevent or interfere with study objectives;
  • * Sensory or other impairment prohibiting the use of a mobile touchscreen device or other study activity (after correction)

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Indiana University,

Richard J Holden, PhD, PRINCIPAL_INVESTIGATOR, Indiana University

Malaz Boustani, MD, PRINCIPAL_INVESTIGATOR, Indiana University

Study Record Dates

2027-07-30